Industry Research Reports

Home > Reports > Service & Software > Global Phenotypic Drug Discovery Market Research Report 2026

Global Phenotypic Drug Discovery Market Research Report 2026

Industry: Service & Software

Published Date: 2026-04-21

Pages: 110 Pages

Report ld: 6573345

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Phenotypic Drug Discovery market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report delivers a comprehensive overview of the global Phenotypic Drug Discovery market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Phenotypic Drug Discovery. The Phenotypic Drug Discovery market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Phenotypic Drug Discovery market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Phenotypic Drug Discovery manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

MARKET SEGMENTATION

By Company

Eurofins Discovery
Sygnature Discovery
PsychoGenics
siTOOLs Biotech
PhoreMost
Charles River
MaxWell
Arctoris

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Platform
Service

Segment by Application

Cancer
Viral Infection
Genetic Disease
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.

Chapter 3: Provides a detailed view of the competitive landscape for Phenotypic Drug Discovery companies, covering revenue share, development plans, and mergers and acquisitions.

Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.

Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.

Chapter 12: Key findings and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Phenotypic Drug Discovery Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Platform

1.2.3 Service

1.3 Market by Application

1.3.1 Global Phenotypic Drug Discovery Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Cancer

1.3.3 Viral Infection

1.3.4 Genetic Disease

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Phenotypic Drug Discovery Market Perspective (2021–2032)

2.2 Global Phenotypic Drug Discovery Growth Trends by Region

2.2.1 Global Phenotypic Drug Discovery Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Phenotypic Drug Discovery Historic Market Size by Region (2021–2026)

2.2.3 Phenotypic Drug Discovery Forecasted Market Size by Region (2027–2032)

2.3 Phenotypic Drug Discovery Market Dynamics

2.3.1 Phenotypic Drug Discovery Industry Trends

2.3.2 Phenotypic Drug Discovery Market Drivers

2.3.3 Phenotypic Drug Discovery Market Challenges

2.3.4 Phenotypic Drug Discovery Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Phenotypic Drug Discovery Players by Revenue

3.1.1 Global Top Phenotypic Drug Discovery Players by Revenue (2021–2026)

3.1.2 Global Phenotypic Drug Discovery Revenue Market Share by Players (2021–2026)

3.2 Global Top Phenotypic Drug Discovery Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Phenotypic Drug Discovery Revenue

3.4 Global Phenotypic Drug Discovery Market Concentration Ratio

3.4.1 Global Phenotypic Drug Discovery Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Phenotypic Drug Discovery Revenue in 2025

3.5 Global Key Players of Phenotypic Drug Discovery Head Offices and Areas Served

3.6 Global Key Players of Phenotypic Drug Discovery, Products and Applications

3.7 Global Key Players of Phenotypic Drug Discovery, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Phenotypic Drug Discovery Breakdown Data by Type

4.1 Global Phenotypic Drug Discovery Historic Market Size by Type (2021–2026)

4.2 Global Phenotypic Drug Discovery Forecasted Market Size by Type (2027–2032)

5 Phenotypic Drug Discovery Breakdown Data by Application

5.1 Global Phenotypic Drug Discovery Historic Market Size by Application (2021–2026)

5.2 Global Phenotypic Drug Discovery Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Phenotypic Drug Discovery Market Size (2021–2032)

6.2 North America Phenotypic Drug Discovery Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Phenotypic Drug Discovery Market Size by Country (2021–2026)

6.4 North America Phenotypic Drug Discovery Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Phenotypic Drug Discovery Market Size (2021–2032)

7.2 Europe Phenotypic Drug Discovery Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Phenotypic Drug Discovery Market Size by Country (2021–2026)

7.4 Europe Phenotypic Drug Discovery Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Phenotypic Drug Discovery Market Size (2021–2032)

8.2 Asia-Pacific Phenotypic Drug Discovery Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Phenotypic Drug Discovery Market Size by Region (2021–2026)

8.4 Asia-Pacific Phenotypic Drug Discovery Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Phenotypic Drug Discovery Market Size (2021–2032)

9.2 Latin America Phenotypic Drug Discovery Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Phenotypic Drug Discovery Market Size by Country (2021–2026)

9.4 Latin America Phenotypic Drug Discovery Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Phenotypic Drug Discovery Market Size (2021–2032)

10.2 Middle East & Africa Phenotypic Drug Discovery Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Phenotypic Drug Discovery Market Size by Country (2021–2026)

10.4 Middle East & Africa Phenotypic Drug Discovery Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Eurofins Discovery

11.1.1 Eurofins Discovery Company Details

11.1.2 Eurofins Discovery Business Overview

11.1.3 Eurofins Discovery Phenotypic Drug Discovery Introduction

11.1.4 Eurofins Discovery Revenue in Phenotypic Drug Discovery Business (2021–2026)

11.1.5 Eurofins Discovery Recent Development

11.2 Sygnature Discovery

11.2.1 Sygnature Discovery Company Details

11.2.2 Sygnature Discovery Business Overview

11.2.3 Sygnature Discovery Phenotypic Drug Discovery Introduction

11.2.4 Sygnature Discovery Revenue in Phenotypic Drug Discovery Business (2021–2026)

11.2.5 Sygnature Discovery Recent Development

11.3 PsychoGenics

11.3.1 PsychoGenics Company Details

11.3.2 PsychoGenics Business Overview

11.3.3 PsychoGenics Phenotypic Drug Discovery Introduction

11.3.4 PsychoGenics Revenue in Phenotypic Drug Discovery Business (2021–2026)

11.3.5 PsychoGenics Recent Development

11.4 siTOOLs Biotech

11.4.1 siTOOLs Biotech Company Details

11.4.2 siTOOLs Biotech Business Overview

11.4.3 siTOOLs Biotech Phenotypic Drug Discovery Introduction

11.4.4 siTOOLs Biotech Revenue in Phenotypic Drug Discovery Business (2021–2026)

11.4.5 siTOOLs Biotech Recent Development

11.5 PhoreMost

11.5.1 PhoreMost Company Details

11.5.2 PhoreMost Business Overview

11.5.3 PhoreMost Phenotypic Drug Discovery Introduction

11.5.4 PhoreMost Revenue in Phenotypic Drug Discovery Business (2021–2026)

11.5.5 PhoreMost Recent Development

11.6 Charles River

11.6.1 Charles River Company Details

11.6.2 Charles River Business Overview

11.6.3 Charles River Phenotypic Drug Discovery Introduction

11.6.4 Charles River Revenue in Phenotypic Drug Discovery Business (2021–2026)

11.6.5 Charles River Recent Development

11.7 MaxWell

11.7.1 MaxWell Company Details

11.7.2 MaxWell Business Overview

11.7.3 MaxWell Phenotypic Drug Discovery Introduction

11.7.4 MaxWell Revenue in Phenotypic Drug Discovery Business (2021–2026)

11.7.5 MaxWell Recent Development

11.8 Arctoris

11.8.1 Arctoris Company Details

11.8.2 Arctoris Business Overview

11.8.3 Arctoris Phenotypic Drug Discovery Introduction

11.8.4 Arctoris Revenue in Phenotypic Drug Discovery Business (2021–2026)

11.8.5 Arctoris Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Phenotypic Drug Discovery Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Platform

Table 3. Key Players of Service

Table 4. Global Phenotypic Drug Discovery Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global Phenotypic Drug Discovery Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Phenotypic Drug Discovery Market Size by Region (US$ Million), 2021–2026

Table 7. Global Phenotypic Drug Discovery Market Share by Region (2021–2026)

Table 8. Global Phenotypic Drug Discovery Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global Phenotypic Drug Discovery Market Share by Region (2027–2032)

Table 10. Phenotypic Drug Discovery Market Trends

Table 11. Phenotypic Drug Discovery Market Drivers

Table 12. Phenotypic Drug Discovery Market Challenges

Table 13. Phenotypic Drug Discovery Market Restraints

Table 14. Global Phenotypic Drug Discovery Revenue by Players (US$ Million), 2021–2026

Table 15. Global Phenotypic Drug Discovery Market Share by Players (2021–2026)

Table 16. Global Top Phenotypic Drug Discovery Players by Tier (Tier 1, Tier 2, and Tier 3), based on Phenotypic Drug Discovery Revenue, 2025

Table 17. Ranking of Global Top Phenotypic Drug Discovery Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by Phenotypic Drug Discovery Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of Phenotypic Drug Discovery, Headquarters and Area Served

Table 20. Global Key Players of Phenotypic Drug Discovery, Products and Applications

Table 21. Global Key Players of Phenotypic Drug Discovery, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global Phenotypic Drug Discovery Market Size by Type (US$ Million), 2021–2026

Table 24. Global Phenotypic Drug Discovery Revenue Market Share by Type (2021–2026)

Table 25. Global Phenotypic Drug Discovery Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global Phenotypic Drug Discovery Revenue Market Share by Type (2027–2032)

Table 27. Global Phenotypic Drug Discovery Market Size by Application (US$ Million), 2021–2026

Table 28. Global Phenotypic Drug Discovery Revenue Market Share by Application (2021–2026)

Table 29. Global Phenotypic Drug Discovery Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global Phenotypic Drug Discovery Revenue Market Share by Application (2027–2032)

Table 31. North America Phenotypic Drug Discovery Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America Phenotypic Drug Discovery Market Size by Country (US$ Million), 2021–2026

Table 33. North America Phenotypic Drug Discovery Market Size by Country (US$ Million), 2027–2032

Table 34. Europe Phenotypic Drug Discovery Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe Phenotypic Drug Discovery Market Size by Country (US$ Million), 2021–2026

Table 36. Europe Phenotypic Drug Discovery Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific Phenotypic Drug Discovery Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific Phenotypic Drug Discovery Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific Phenotypic Drug Discovery Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America Phenotypic Drug Discovery Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America Phenotypic Drug Discovery Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America Phenotypic Drug Discovery Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa Phenotypic Drug Discovery Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa Phenotypic Drug Discovery Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa Phenotypic Drug Discovery Market Size by Country (US$ Million), 2027–2032

Table 46. Eurofins Discovery Company Details

Table 47. Eurofins Discovery Business Overview

Table 48. Eurofins Discovery Phenotypic Drug Discovery Product

Table 49. Eurofins Discovery Revenue in Phenotypic Drug Discovery Business (US$ Million), 2021–2026

Table 50. Eurofins Discovery Recent Development

Table 51. Sygnature Discovery Company Details

Table 52. Sygnature Discovery Business Overview

Table 53. Sygnature Discovery Phenotypic Drug Discovery Product

Table 54. Sygnature Discovery Revenue in Phenotypic Drug Discovery Business (US$ Million), 2021–2026

Table 55. Sygnature Discovery Recent Development

Table 56. PsychoGenics Company Details

Table 57. PsychoGenics Business Overview

Table 58. PsychoGenics Phenotypic Drug Discovery Product

Table 59. PsychoGenics Revenue in Phenotypic Drug Discovery Business (US$ Million), 2021–2026

Table 60. PsychoGenics Recent Development

Table 61. siTOOLs Biotech Company Details

Table 62. siTOOLs Biotech Business Overview

Table 63. siTOOLs Biotech Phenotypic Drug Discovery Product

Table 64. siTOOLs Biotech Revenue in Phenotypic Drug Discovery Business (US$ Million), 2021–2026

Table 65. siTOOLs Biotech Recent Development

Table 66. PhoreMost Company Details

Table 67. PhoreMost Business Overview

Table 68. PhoreMost Phenotypic Drug Discovery Product

Table 69. PhoreMost Revenue in Phenotypic Drug Discovery Business (US$ Million), 2021–2026

Table 70. PhoreMost Recent Development

Table 71. Charles River Company Details

Table 72. Charles River Business Overview

Table 73. Charles River Phenotypic Drug Discovery Product

Table 74. Charles River Revenue in Phenotypic Drug Discovery Business (US$ Million), 2021–2026

Table 75. Charles River Recent Development

Table 76. MaxWell Company Details

Table 77. MaxWell Business Overview

Table 78. MaxWell Phenotypic Drug Discovery Product

Table 79. MaxWell Revenue in Phenotypic Drug Discovery Business (US$ Million), 2021–2026

Table 80. MaxWell Recent Development

Table 81. Arctoris Company Details

Table 82. Arctoris Business Overview

Table 83. Arctoris Phenotypic Drug Discovery Product

Table 84. Arctoris Revenue in Phenotypic Drug Discovery Business (US$ Million), 2021–2026

Table 85. Arctoris Recent Development

Table 86. Research Programs/Design for This Report

Table 87. Key Data Information from Secondary Sources

Table 88. Key Data Information from Primary Sources

Table 89. Authors List of This Report

List of Figures

Figure 1. Phenotypic Drug Discovery Picture

Figure 2. Global Phenotypic Drug Discovery Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Phenotypic Drug Discovery Market Share by Type: 2025 vs 2032

Figure 4. Platform Features

Figure 5. Service Features

Figure 6. Global Phenotypic Drug Discovery Market Size by Application (US$ Million), 2021–2032

Figure 7. Global Phenotypic Drug Discovery Market Share by Application: 2025 vs 2032

Figure 8. Cancer Case Studies

Figure 9. Viral Infection Case Studies

Figure 10. Genetic Disease Case Studies

Figure 11. Others Case Studies

Figure 12. Phenotypic Drug Discovery Report Years Considered

Figure 13. Global Phenotypic Drug Discovery Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global Phenotypic Drug Discovery Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Phenotypic Drug Discovery Market Share by Region: 2025 vs 2032

Figure 16. Global Phenotypic Drug Discovery Market Share by Players in 2025

Figure 17. Global Phenotypic Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Phenotypic Drug Discovery Revenue in 2025

Figure 19. North America Phenotypic Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America Phenotypic Drug Discovery Market Share by Country (2021–2032)

Figure 21. United States Phenotypic Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada Phenotypic Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Phenotypic Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Phenotypic Drug Discovery Market Share by Country (2021–2032)

Figure 25. Germany Phenotypic Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France Phenotypic Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. Phenotypic Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy Phenotypic Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia Phenotypic Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland Phenotypic Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Phenotypic Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Phenotypic Drug Discovery Market Share by Region (2021–2032)

Figure 33. China Phenotypic Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan Phenotypic Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea Phenotypic Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia Phenotypic Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India Phenotypic Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand Phenotypic Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Phenotypic Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Phenotypic Drug Discovery Market Share by Country (2021–2032)

Figure 41. Mexico Phenotypic Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil Phenotypic Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Phenotypic Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Phenotypic Drug Discovery Market Share by Country (2021–2032)

Figure 45. Israel Phenotypic Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia Phenotypic Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE Phenotypic Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Eurofins Discovery Revenue Growth Rate in Phenotypic Drug Discovery Business (2021–2026)

Figure 49. Sygnature Discovery Revenue Growth Rate in Phenotypic Drug Discovery Business (2021–2026)

Figure 50. PsychoGenics Revenue Growth Rate in Phenotypic Drug Discovery Business (2021–2026)

Figure 51. siTOOLs Biotech Revenue Growth Rate in Phenotypic Drug Discovery Business (2021–2026)

Figure 52. PhoreMost Revenue Growth Rate in Phenotypic Drug Discovery Business (2021–2026)

Figure 53. Charles River Revenue Growth Rate in Phenotypic Drug Discovery Business (2021–2026)

Figure 54. MaxWell Revenue Growth Rate in Phenotypic Drug Discovery Business (2021–2026)

Figure 55. Arctoris Revenue Growth Rate in Phenotypic Drug Discovery Business (2021–2026)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Phenotypic Drug Discovery market? zhanKai

The top companies in the global Phenotypic Drug Discovery market are Eurofins Discovery、Sygnature Discovery、PsychoGenics.

Related Reports

Phenotypic Drug Discovery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Phenotypic Drug Discovery was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 105
USD 3950.00
(Single User License)
Global Phenotypic Drug Discovery Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Phenotypic Drug Discovery market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 125
USD 4900.00
(Single User License)
Phenotypic Drug Discovery- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Phenotypic Drug Discovery was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 90
USD 3950.00
(Single User License)
Global Phenotypic Drug Discovery Market Research Report 2025
The global market for Phenotypic Drug Discovery was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 72
USD 2900.00
(Single User License)
Global Phenotypic Drug Discovery Market Insights, Forecast to 2030
Market Analysis and Insights: Global Phenotypic Drug Discovery Market
Published Date: 2024-04-11
Pages: 99
USD 4900.00
(Single User License)
Global Phenotypic Drug Discovery Market Research Report 2024
The global Phenotypic Drug Discovery market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-17
Pages: 70
USD 2900.00
(Single User License)
Phenotypic Drug Discovery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Phenotypic Drug Discovery was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-06
Pages: 97
USD 3950.00
(Single User License)

Phenotypic Drug Discovery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Phenotypic Drug Discovery was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 105
USD 3950.00 (Single User License)
Global Phenotypic Drug Discovery Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Phenotypic Drug Discovery market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 125
USD 4900.00 (Single User License)
Phenotypic Drug Discovery- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Phenotypic Drug Discovery was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 90
USD 3950.00 (Single User License)
Global Phenotypic Drug Discovery Market Research Report 2025
The global market for Phenotypic Drug Discovery was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 72
USD 2900.00 (Single User License)
Global Phenotypic Drug Discovery Market Insights, Forecast to 2030
Market Analysis and Insights: Global Phenotypic Drug Discovery Market
Published: 2024-04-11
Pages: 99
USD 4900.00 (Single User License)
Global Phenotypic Drug Discovery Market Research Report 2024
The global Phenotypic Drug Discovery market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-17
Pages: 70
USD 2900.00 (Single User License)
Phenotypic Drug Discovery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Phenotypic Drug Discovery was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-06
Pages: 97
USD 3950.00 (Single User License)